Dejan Loncar - PhD Health Economist

Key Expert Consultant / Senior Health Financing Specialist at The Global Fund (TGF)

Coordinating TGF Health Financing to support countries in grant co-financing review, PfR, DLI and social contracting; leading analytical and modeling group to conduct economic evaluations, market access, pricing, risk and impact modeling.

STATA Instructor East Europe at STATA Corporation

Conducting STATA software courses related to data management and econometrics.

Senior Health Economist – Translation Study at Bill and Melinda Gates Foundation (BMGF)

Prepared Translation Study of Cost effectiveness of Moxidectin versus Ivermectin.

Senior Health Economist – Economic Evaluation of Obesity at Novo Nordisk Pharma

Conducted Economic Evaluation Assessment of Obesity in 3 countries and published the article.

Health Information System (HIS) Adviser at WHO

Provided key recommendations of HIS design to support national clinical trials and tracking of expenditures.

Health Financing Specialist – COVID-19 Response at The Global Fund (TGF)

Coordinated COVID-19 health financing response and analyzed/ developed portfolio investments.

Senior M&E Specialist - Data Specialist at UN Mine Action (UNMAS, UNDP, UNICEF, UNOPS)

Developed M&E framework, tools, DQA processes; led quantitative analysis of M&E data for results reporting and advised country offices on data collection methods.

Senior Programme Manager – Economics and Financing at Global Alliance for Vaccination and Immunization (GAVI)

Led dialogue with ministries on immunization financing, sustainability & transition plans; developed transition risk assessments and procurement planning.

Health Investment and Financing and Quantitative Specialist at The Global Fund (TGF)

Conducted national health financing analysis, assessed co-financing compliance and evaluated grant renewal progress; designed PfR, DLI and social contracting mechanisms; performed econometric analyses and built country capacity for economic evaluations.

Quantitative Financing Specialist - Programme Adviser at UNAIDS

Advised portfolio management and M&E in EC-funded projects; led NASA analyses and developed HIV spending projections, cost-effectiveness and impact analyses.

Project Evaluation Officer at WHO

Managed M&E frameworks for TC/HTP projects; conducted internal evaluations and supported EC project governance.

Data Analyst at WHO

Developed burden of disease database; data management, statistical analyses, and methodological improvements for population health studies.

Research Programme Associate at IOM

Research and data analysis; contributed to design/implementation of global health studies and data systems.

Senior Health Financing Specialist at The Global Fund (TGF)

Coordinating health financing analyses, grant co-financing review, PfR and DLI design; leading analytical and modeling efforts on economic evaluations, access-to-market, pricing, risk and impact modeling; supporting social contracting and health financing policy development.

Senior Lecturer at University of Geneva

Lecturer in Health Economics, Applied Econometrics and Monitoring & Evaluation; developing courses and supervising master/PhD level work; leading analytical projects and supporting UN and IO partnerships.

Principal Health Financing Specialist at World Health Organization (Kabul)

Led Health Financing Assessment and Policy Options, Fiscal Space analysis, PfR and social contracting analysis; supported transition and sustainability planning for health programs.

Senior Health Economist – Modeler at Institute of Global Health (IoGH), Geneva

Led health economic analysis and mathematical modeling (HEOR, RWE, cost-effectiveness, budget impact); coordinated with UN agencies and international partners; led Geneva Analytical Group activities.

Senior Health Economist at Merck (Washington)

Led HTA modeling (CEA and Budget Impact) of immunotherapy and biomarkers across multiple countries; supported engagement with government stakeholders; conducted economic impact analyses and affordability studies.

Senior Health Economist at UNAIDS – Geneva

Modeled HIV/AIDS expenditure, conducted NASA-like analyses, health financing inputs; contributed to policy papers and HTA adaptations; supported cross-border telehealth policy options.

Senior Health Financing Quantitative Analyst at Novo Nordisk Pharma – Copenhagen

Technical and allocative efficiency, impact analysis of HIV programs and national HIV costing exercise; contributed to HTA dossiers and market access.

Senior M&E Data Specialist at UN Mine Action (UNMAS/UNDP/UNICEF/UNOPS)

Developed M&E framework and mechanism for United Mine Action Strategy 2019-2023; built data collection tools and dashboards; conducted quantitative analyses and reporting to IACG-MA.

STATA Instructor at STATA Corporation

Instructor delivering STATA software courses related to data management and econometrics.

Senior Health Economist at Bill & Melinda Gates Foundation

Prepared Translation Study of Cost effectiveness of Moxidectin versus Ivermectin.

Senior Health Economist at Novo Nordisk Pharma

Health economic outcomes modeling and HTA related work including obesity in three countries.

Health Information System Adviser at World Health Organization

Provided key recommendations of HIS design to support national clinical trials and tracking of expenditures.

Modeler / Health Economist at Pfizer

Conduced HTA modeling (CEA and Budget Impact Analysis) of immunotherapy and biomarkers in multiple countries.

Health Financing Quantitative Analyst at UNAIDS

Conduced analyses of OECD HIV/AIDS investments and supported policy papers and HTA adaptation.

Senior Researcher at Digital Hub - University of Geneva

Led scoping reviews and supported analytical work for UN agencies and IOs; managed Geneva Analytical Group.

Senior Health Financing Consultant at German Development Bank – KfW /GFA consultancy group

Developed Covid-19 Preparedness and Response Investment Framework; portfolio investments and risk analysis.

Senior HIS/RHIS Specialist at WHO

Developed RHIS for NCD and CD technical packages; RHIS readiness assessment methodology and RHIS Investment Case.

Senior Health Financing Specialist at The Global Fund (TGF)

Coordinated COVID-19 Health Financing response and analyzed portfolio investments.

Health Economist at World Health Organization

HEOR analyses and modeling for EMAPEC project on air pollutants; burden-of-disease analyses.

Senior Quantitative Analyst at WHO Copenhagen

Burden of Disease analyses and HIS assessments in Montenegro.

Structural Equation Modeler at UNAIDS

Developed SEM to assess social enablers on HIV/AIDS health outcomes.

Senior Health Financing Specialist at German Development Bank – GFE Consulting Group

Feasibility study – Blockchain technology for health financing.

Lead, COVID-19 Resource Needs Assessment at Institute of Global Health

Led COVID-19 resource needs estimation and procurement tool development.

Principal Health Financing Specialist at WHO Kabul

Led Health Financing Assessment (HFA) in Afghanistan; produced HFA report, fiscal space assessment, PfR and social contracting analysis.

Principal Health Economist / Modeler at University Hospital of Geneva (HUG)

Led cost-effective and cost-benefit studies of Team-Based Healthcare for multi-diagnosis patients.

M&E Advisor at Specchio project, Population Epidemiology Unit / University Hospital of Geneva

Developed M&E framework and mechanisms; led quantitative M&E analyses and data visualization.

Health Economist at Hospital University of Geneva

Developed Health Economic Impact Evaluation Plan.

Econometrician / Health Economist at Guy's and St Thomas Hospital

Economic analyses for HIV treatment strategies; data quality oversight and modeling.

M&E Specialist at WHO Copenhagen

Developed M&E indicators for WHO country programmes.